The 2025 BIO Asia–Taiwan officially kicks off! On Day 1, global biotech leaders—from Tang Prize laureates to ICBA Chair and Amgen VPs—shared cutting-edge insights on the future of biotech.

Key Highlights:
ICBA Chair: “Now is the time for change”—emphasizing regulatory innovation & cross-border collaboration
Amgen: Calls for biotech investment in Asia’s rapidly aging populations & rising cardiovascular risk
Jens Juul Holst: Reveals the discovery journey of GLP-1, a drug that may go beyond diabetes—potentially aiding in neuroprotection, addiction treatment, and even cancer prevention

Dive into the full report: https://reurl.cc/XQj6O3

#Globalbio #BIOAsiaTaiwan #GLP1 #BiotechInnovation #CardioHealth #HealthyAging #DrugDiscovery #AddictionScience #CancerTherapies #AIinBiotech